RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Talkmed Group Dividend 2024

Talkmed Group Dividend

0.02 SGD

Talkmed Group Dividend yield

6.08 %

Ticker

5G3.SI

ISIN

SG2G61000003

How much dividend does Talkmed Group 2024 pay?

According to the latest status from May 2024, Talkmed Group paid a total of 0.02 SGD per share in dividends within the last 12 months. With the current Talkmed Group price of 0.4 SGD, this corresponds to a dividend yield of 6.08 %. A dividend is paid times per year.

6.08 % Dividend Yield=
0.02 SGD Dividend
0.4 SGD Stock Price

Historical Talkmed Group Dividends

A dividend is paid times per year. Last year, the payout months were May and September.

PaydateDividend
5/30/20240.01
9/14/20230.01
5/28/20230.02
9/11/20220.02
5/28/20220.01
9/11/20210.01
5/27/20210.01
12/17/20200.01
5/28/20200.01
9/13/20190.01
6/3/20190.01
9/14/20180.01
5/27/20180.01
9/14/20170.01
5/28/20170.01
9/10/20160.02
6/4/20160.02
10/8/20150.02
6/4/20150.02
9/13/20140.02
1
2

Talkmed Group Stock Dividend

Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Talkmed Group provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Talkmed Group’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Talkmed Group's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Talkmed Group Dividend History

DateTalkmed Group Dividend
2024e0.02 SGD
20230.02 SGD
20220.02 SGD
20210.01 SGD
20200.02 SGD
20190.02 SGD
20180.02 SGD
20170.02 SGD
20160.02 SGD
20150.02 SGD
20140.02 SGD

Is the Talkmed Group Dividend Safe?

Talkmed Group has been increasing the dividend for 2 years.

Over the past 10 years, Talkmed Group has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 2.406%.

Analysts expect a Dividend Increase of 1.242% for the current fiscal year.

Dividend Details

Understanding Talkmed Group's Dividend Distributions

Talkmed Group’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Talkmed Group's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Talkmed Group's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Talkmed Group’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Talkmed Group Aktienanalyse

What does Talkmed Group do?

Talkmed Group Ltd. is a leading healthcare company in Asia specializing in the development, manufacturing, and marketing of innovative diagnostic and therapeutic solutions in oncology. The company was founded in 2002 by Dr. Ang Peng Tiam, with a focus on providing high-quality cancer treatments. Since its inception, Talkmed Group Ltd. has become a pioneer in cancer research and treatment in Asia and has grown to become one of the largest providers of cancer treatments in the region. The company's business model is centered around offering high-quality diagnostic solutions and innovative cancer therapies to provide better patient care. They work closely with pharmaceutical companies to develop and market innovative medications and therapies that contribute to higher survival rates and improved quality of life for cancer patients. In addition, Talkmed Group Ltd. is involved in the development of medical diagnostic and monitoring devices tailored to the needs of cancer patients. They offer a range of treatments and programs that aim to provide accessible, affordable, and high-quality care for cancer patients. Overall, Talkmed Group Ltd. is an innovative company dedicated to improving the lives of cancer patients through the development, manufacturing, and marketing of diagnostic and therapeutic solutions in oncology. Talkmed Group is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Talkmed Group Stock

How much dividend does Talkmed Group pay?

Over the past 12 months, Talkmed Group paid a dividend of 0.02 SGD . This corresponds to a dividend yield of about 6.08 %. For the coming 12 months, Talkmed Group is expected to pay a dividend of 0.02 SGD.

What is the dividend yield of Talkmed Group?

The current dividend yield of Talkmed Group is 6.08 %.

When does Talkmed Group pay dividends?

Talkmed Group pays a quarterly dividend. This is distributed in the months of September, May, September, May.

How secure is the dividend of Talkmed Group?

Talkmed Group paid dividends every year for the past 11 years.

What is the dividend of Talkmed Group?

For the upcoming 12 months, dividends amounting to 0.02 SGD are expected. This corresponds to a dividend yield of 6.08 %.

In which sector is Talkmed Group located?

Talkmed Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Talkmed Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Talkmed Group from 5/10/2024 amounting to 0.013 SGD, you needed to have the stock in your portfolio before the ex-date on 4/30/2024.

When did Talkmed Group pay the last dividend?

The last dividend was paid out on 5/10/2024.

What was the dividend of Talkmed Group in the year 2023?

In the year 2023, Talkmed Group distributed 0.024 SGD as dividends.

In which currency does Talkmed Group pay out the dividend?

The dividends of Talkmed Group are distributed in SGD.

Andere Kennzahlen von Talkmed Group

Our stock analysis for Talkmed Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Talkmed Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.